Autres langues ReproCELL Incorporated

Actions

4978

JP3974770004

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 30/04/2024			Varia. 5j.	Varia. 1 janv.
137 ^JPY	+1,48 %		-1,44 %	-21,71 %

2023	ReproCELL Incorporated publie ses résultats pour l'exercice clos le 31 mars 2023	CI
2022	REPROCELL signe un accord pour collecter de manière prospective des échantillons pour l'étude du microbiome de l'IFF	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd.	21/12
ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding	05/12
ReproCELL Incorporated Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23
Clinical Trials: An Evolutionary Perspective	18/01/23
Histocell, S.L. announced that it expects to receive ?0.4 million in funding from ReproCELL Incorporated	08/11/22
ReproCELL Incorporated : 4 ways ex vivo models offer Pharma better alternatives to animal testing	01/11/22
ReproCELL Incorporated : How human fresh tissue models are helping RCD405 achieve regulatory approval	17/08/22
ReproCELL Incorporated : Everything we know about the 5HT1B receptor	21/04/22
REPROCELL Signs Agreement to Prospectively Collect Samples for IFF's Microbiome Study	20/04/22
ReproCELL Incorporated : Skin biopsy and ex vivo culture methods	29/03/22
ReproCELL Incorporated : The influence of the microbiome on inflammatory bowel diease	18/03/22
ReproCELL Incorporated : What is Human Tissue Testing?	14/03/22
ReproCELL Incorporated : co-author paper with IBM showcasing a novel ML driven precision medicine strategy for drug development	08/03/22
ReproCELL Incorporated : Solutions for Skin Disease Researchers	04/03/22
ReproCELL Incorporated : Predicting Psoriasis Drug Efficacy in Human Skin	03/03/22
ReproCELL Incorporated : How SynFire® Technology can benefit your research	03/03/22
ReproCELL Incorporated : Inserts or plates for your 3D cell culture?	28/02/22
ReproCELL Incorporated : How to improve your 3D Cell Culture using Small-scale Perfusion Systems	15/02/22
ReproCELL Incorporated : Biotechgate Digital Partnering 2022 7 - 11 February 2022 • Virtual Meeting	10/02/22
ReproCELL Incorporated : Enhance your epithelial barriers assay using Alvetex	07/02/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ReproCELL Incorporated

Actions

4978

JP3974770004

Autres langues

Filtres